AlphAIalphai — Financial news for AI agents
benzinga.comJUL 294 min read$TLRY

Tilray Brands (TLRY) Stock Is Trending: Here's What You Should Know - Tilray Brands (NASDAQ:TLRY)

Tilray Brands (NASDAQ:TLRY) shares rose 2.23% to $4.12 in after-hours after reporting Q4 results for the period ended May 31. Revenue was $281.7M, above the $254.53M estimate. EPS was $0.05 versus $0.21 consensus. FY2026 revenue rose to $915.5M and adjusted EBITDA to $61.1M. FY2027 adjusted EBITDA guidance is $68M-$75M.

Original reporting
benzinga.com
Published Jul 29, 2026, 6:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 6:59 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Tilray Brands (TLRY) Stock Is Trending: Here's What You Should Know - Tilray Brands (NASDAQ:TLRY) — source image
Source · benzinga.com
Decision brief

The 30-second read

$TLRYBullishMed
01

Why it matters

The combination of a revenue beat, higher gross profit, and a specific FY27 adjusted EBITDA range is likely to drive re-rating attempts, but the EPS miss and weak technical backdrop can limit sustained momentum.

02

Market read

Traders get a fresh earnings-and-guidance package tied to an after-hours move, plus quantified profitability and margin changes.

03

What to watch

Adjusted EBITDA excludes fuel surcharge impact (~$2.3M in Q4), so investors may scrutinize underlying margin durability and whether gross margin improvement (32% Q4) is sustainable into FY27.

Relevance 8/10Novelty 7/10Timing: after-hours reaction to Q4 results released after the close

Background

Tilray reported Q4 and fiscal year results for the period ended May 31, with the article framing the post-close reaction and key financial metrics.

Company-level read

Ticker impact

$TLRYBullishMedium confidence
Context

Tilray shares jumped after-hours after Q4 revenue beat estimates ($281.7M vs $254.53M) and it guided FY27 adjusted EBITDA of $68M to $75M.

Expected impact

Choppy upside bias after-hours, with follow-through dependent on investor focus on EBITDA guidance versus the large EPS miss.

Evidence & confidence

The article provides fresh, decision-relevant datapoints: after-hours move tied to Q4 results, FY27 adjusted EBITDA guidance range, and quantified misses (EPS) plus weak RSI/52-week positioning.

Market effects

Sector

Incremental read-through for cannabis beverage peers on whether revenue growth is translating into improving gross profit and EBITDA.

Regional

Limited; primarily a single-name catalyst with no broader macro/regulatory trigger cited.

Global

Low; no international policy, supply chain, or cross-border deal details provided.

Counterpoint

What could challenge this read

The revenue beat may not be enough if investors anchor on the large EPS miss ($0.05 vs $0.21) and the stock remains technically weak (RSI ~33, near 52-week lows).

Key entities

  • public_company
    Tilray Brands Inc.

    NASDAQ-listed cannabis and beverage company reporting Q4 and FY26 results and providing FY27 adjusted EBITDA guidance.

  • executive
    Irwin D. Simon

    Chairman and CEO quoted on the company’s FY26 milestone and platform evolution.

Read at source← All news

Related articles

AUG 7
$TLRYMed

Tilray Brands (TLRY) Is Up 5.7% After Narrower Loss, ESOP Shelf Filing and M&A Signal

Tilray Brands reported Q4 sales of US$281.71 million and full-year sales of US$915.45 million for the year ended May 31, 2026, with a substantially smaller net loss than the prior year. The company also filed a US$47.69 million shelf registration for 11,355,231 common shares tied to its ESOP. Management said at-the-market equity proceeds may fund acquisitions, including deals like BrewDog.

simplywall.st7 min
JUL 30
$TLRYMed

Tilray Brands Q4 Earnings Call Highlights

Tilray Brands (NASDAQ: TLRY) reported fiscal 2026 results on its Q4 earnings call. Net loss narrowed to $105.2M ($1.09/share) from about $2.2B in fiscal 2025. Adjusted net income rose 87% to $12.2M. Cannabis and distribution revenue grew, BrewDog added beverage revenue, and Tilray guided adjusted EBITDA of $68M to $75M for fiscal 2027.

yahoo.com6 min
JUL 29
$TLRYMed

Tilray Brands reports record US$915.5M revenue in Fiscal 2026

Tilray Brands reported record fiscal 2026 revenue of US$915.5M, up 11% from US$821.3M, driven by cannabis, beverage, distribution and wellness. Beverage net revenue rose 6% to US$254.0M, with Q4 beverage revenue up 61% to US$105M. Adjusted EBITDA increased to US$61.1M. Tilray completed a £33M BrewDog acquisition in March. It forecasts fiscal 2027 adjusted EBITDA of US$68M to US$75M.

foodbusinessmea.com4 min
JUL 29
$TLRYMedAI 8/10

Tilray Brands Q4 revenue beats estimates by 10.7%, shares rise 2.23%

Tilray Brands reported Q4 net revenue of $281.7 million for the period ended May 31, up 10.7% versus the $254.53 million consensus estimate, and shares rose 2.23% to $4.12 after hours. Adjusted EPS was $0.05, missing the $0.21 consensus. For FY26, net revenue rose 11% to $915.5 million; adjusted EBITDA increased to $61.1 million.

scanx.trade4 min
JUL 28
$TLRYMed

Tilray Brands Q4 Results: Adj. EPS beats estimate, sales up 25%

Tilray Brands (NASDAQ: TLRY) reported Q4 adjusted EPS of $0.05, versus a $(0.01) analyst consensus, and quarterly sales of $281.714 million versus $246.377 million expected. Sales rose 25.47% year over year to $281.714 million, while adjusted EPS fell 75% from $0.20. The company also noted Revolver’s Blood & Honey spirits launch in Texas.

scanx.trade5 min